08 April 2022>: Clinical Research
A Retrospective Study to Determine the Association Between Serum Albumin Levels and Atrial Fibrillation by Sex in 950 Patients from a Single Center in China
Xia Zhong 1ACDE , Huachen Jiao 2ADEG* , Dongsheng Zhao 1BCF , Jing Teng 1ADF , Mengqi Yang 1CFDOI: 10.12659/MSM.935347
Med Sci Monit 2022; 28:e935347
Table 1 Baseline characteristics of AF group and controls.
Variable | AF group (n=950) | Control group (n=963) | P value |
---|---|---|---|
Age, years | 68.61±10.34 | 67.92±11.66 | 0.171 |
Male, n (%) | 479 (50.4) | 470 (48.8) | 0.480 |
CHD, n (%) | 840 (88.4) | 241 (25.0) | * |
Hypertension, n (%) | 638 (67.2) | 324 (33.6) | * |
Diabetes, n (%) | 280 (29.5) | 158 (16.4) | * |
TG, mmol/L | 1.07 [0.78–1.46] | 1.10 [0.81–1.55] | 0.029* |
TC, mmol/L | 4.19±1.10 | 5.02±1.10 | * |
LDL-C, mmol/L | 2.50±0.90 | 2.96±0.86 | * |
HDL-C, mmol/L | 1.07±0.30 | 1.21±0.25 | * |
ALT, U/L | 16.00 [12.00–24.00] | 17.00 [12.00–23.00] | 0.429 |
AST, U/L | 20.00 [16.00–25.00] | 18.00 [15.00–23.00] | * |
APOA1, g/L | 1.13±0.26 | 1.23±0.25 | * |
APOB, g/L | 0.80±0.38 | 0.99±0.24 | * |
Lp (a), mg/dL | 14.20 [6.80–29.70] | 14.60 [6.90–29.30] | 0.970 |
SCr, μmoI/L | 78.46±51.47 | 64.77±26.54 | * |
SUA, mg/dL | 5.71±1.91 | 5.21±1.50 | * |
ALB, g/L | 38.05±4.64 | 40.11±4.12 | * |
Male, g/L | 37.96±4.77 | 40.62±4.04 | * |
Female, g/L | 38.14±4.51 | 39.63±4.14 | * |
Hypoproteinemia, n (%) | 211 (22.21) | 98 (10.17) | * |
Male | 112 (11.79) | 40 (4.15) | * |
Female | 99 (10.42) | 58 (6.02) | * |
Data are presented as mean±SD or n(%). AF – atrial fibrillation; CHD – coronary heart disease; AST – aspartate aminotransferase; ALT – alanine aminotransferase; APOA1 – serum apolipoprotein A1; APOB – serum apolipoprotein B; ALB – serum albumin; Lp (a) – lipoprotein (a); TG – triglyceride; TC – total cholesterol; LDL-C – low-density lipoprotein cholesterol; HDL-C – high-density lipoprotein cholesterol; SCr – serum creatinine; SUA – serum uric acid. * Statistically significant value ( |